Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson’s Disease With and Without Depression (History)

Patients with Parkinson’s disease (PD) are often treated with dopaminergic medication. Dopaminergic medication is known to improve both motor and certain nonmotor symptoms, such as depression. However, it can contribute to behavioral impairment, for example, by enhancing risky choice. Here we charac...

Full description

Bibliographic Details
Main Authors: Monique H. M. Timmer, Guillaume Sescousse, Rianne A. J. Esselink, Payam Piray, Roshan Cools
Format: Article
Language:English
Published: The MIT Press 2018-02-01
Series:Computational Psychiatry
Subjects:
Online Access:https://www.mitpressjournals.org/doi/pdf/10.1162/CPSY_a_00011
id doaj-9e037f2ef0e4418cabe0e5c7c875f6e5
record_format Article
spelling doaj-9e037f2ef0e4418cabe0e5c7c875f6e52020-11-24T23:29:16ZengThe MIT PressComputational Psychiatry2379-62272018-02-012112710.1162/CPSY_a_00011CPSY_a_00011Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson’s Disease With and Without Depression (History)Monique H. M. Timmer0Guillaume Sescousse1Rianne A. J. Esselink2Payam Piray3Roshan Cools4Donders Institute for Brain, Cognition and Behaviour, Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, the NetherlandsDonders Institute for Brain, Cognition and Behaviour, Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, the NetherlandsDonders Institute for Brain, Cognition and Behaviour, Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, the NetherlandsDonders Institute for Brain, Cognition and Behaviour, Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, the NetherlandsDepartment of Psychiatry, Radboud University Medical Centre, Nijmegen, the NetherlandsPatients with Parkinson’s disease (PD) are often treated with dopaminergic medication. Dopaminergic medication is known to improve both motor and certain nonmotor symptoms, such as depression. However, it can contribute to behavioral impairment, for example, by enhancing risky choice. Here we characterize the computational mechanisms that contribute to dopamine-induced changes in risky choice in PD patients with and without a depression (history). We adopt a clinical–neuroeconomic approach to investigate the effects of dopaminergic medication on specific components of risky choice in PD. Twenty-three healthy controls, 21 PD patients with a depression (history), and 22 nondepressed PD patients were assessed using a well-established risky choice paradigm. Patients were tested twice: once after taking their normal dopaminergic medication and once after withdrawal of their medication. Dopaminergic medication increased a value-independent gambling propensity in nondepressed PD patients, while leaving loss aversion unaffected. By contrast, dopaminergic medication effects on loss aversion were associated with current depression severity and with drug effects on depression scores. The present findings demonstrate that dopaminergic medication increases a value-independent gambling bias in nondepressed PD patients. Moreover, the current study raises the hypothesis that dopamine-induced reductions in loss aversion might underlie previously observed comorbidity between depression and medication-related side effects in PD, such as impulse control disorder.https://www.mitpressjournals.org/doi/pdf/10.1162/CPSY_a_00011Parkinson’s diseasedepressionrisky choicedopamineloss aversionprospect theory
collection DOAJ
language English
format Article
sources DOAJ
author Monique H. M. Timmer
Guillaume Sescousse
Rianne A. J. Esselink
Payam Piray
Roshan Cools
spellingShingle Monique H. M. Timmer
Guillaume Sescousse
Rianne A. J. Esselink
Payam Piray
Roshan Cools
Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson’s Disease With and Without Depression (History)
Computational Psychiatry
Parkinson’s disease
depression
risky choice
dopamine
loss aversion
prospect theory
author_facet Monique H. M. Timmer
Guillaume Sescousse
Rianne A. J. Esselink
Payam Piray
Roshan Cools
author_sort Monique H. M. Timmer
title Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson’s Disease With and Without Depression (History)
title_short Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson’s Disease With and Without Depression (History)
title_full Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson’s Disease With and Without Depression (History)
title_fullStr Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson’s Disease With and Without Depression (History)
title_full_unstemmed Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson’s Disease With and Without Depression (History)
title_sort mechanisms underlying dopamine-induced risky choice in parkinson’s disease with and without depression (history)
publisher The MIT Press
series Computational Psychiatry
issn 2379-6227
publishDate 2018-02-01
description Patients with Parkinson’s disease (PD) are often treated with dopaminergic medication. Dopaminergic medication is known to improve both motor and certain nonmotor symptoms, such as depression. However, it can contribute to behavioral impairment, for example, by enhancing risky choice. Here we characterize the computational mechanisms that contribute to dopamine-induced changes in risky choice in PD patients with and without a depression (history). We adopt a clinical–neuroeconomic approach to investigate the effects of dopaminergic medication on specific components of risky choice in PD. Twenty-three healthy controls, 21 PD patients with a depression (history), and 22 nondepressed PD patients were assessed using a well-established risky choice paradigm. Patients were tested twice: once after taking their normal dopaminergic medication and once after withdrawal of their medication. Dopaminergic medication increased a value-independent gambling propensity in nondepressed PD patients, while leaving loss aversion unaffected. By contrast, dopaminergic medication effects on loss aversion were associated with current depression severity and with drug effects on depression scores. The present findings demonstrate that dopaminergic medication increases a value-independent gambling bias in nondepressed PD patients. Moreover, the current study raises the hypothesis that dopamine-induced reductions in loss aversion might underlie previously observed comorbidity between depression and medication-related side effects in PD, such as impulse control disorder.
topic Parkinson’s disease
depression
risky choice
dopamine
loss aversion
prospect theory
url https://www.mitpressjournals.org/doi/pdf/10.1162/CPSY_a_00011
work_keys_str_mv AT moniquehmtimmer mechanismsunderlyingdopamineinducedriskychoiceinparkinsonsdiseasewithandwithoutdepressionhistory
AT guillaumesescousse mechanismsunderlyingdopamineinducedriskychoiceinparkinsonsdiseasewithandwithoutdepressionhistory
AT rianneajesselink mechanismsunderlyingdopamineinducedriskychoiceinparkinsonsdiseasewithandwithoutdepressionhistory
AT payampiray mechanismsunderlyingdopamineinducedriskychoiceinparkinsonsdiseasewithandwithoutdepressionhistory
AT roshancools mechanismsunderlyingdopamineinducedriskychoiceinparkinsonsdiseasewithandwithoutdepressionhistory
_version_ 1725546520240979968